References
- Schwartz R H. Immune response (Ir) genes of the murine major histocompatibility complex. Adv Immunol 1986; 38: 31–201
- Bjorkman P, Saper M, Samraoui B, Bennett W, Strominger J, Wiley D. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987; 329: 512–519
- Tiwari J, Terasaki P. HLA and disease associations. Springer-Verlag, New York 1985
- Pellegrino M A, Russo C, Allison J. HLA antigens in serum. Methods Enzymol 1984; 108: 614–624
- Krangel M S. Secretion of HLA-A and-B antigens via an alternative RNA splicing pathway. J Exp Med 1986; 163: 1173–1190
- Jendro M, Goronzy J J, Weyand C M. Structural and functional characterization of HLA-DR molecules circulating in the serum. 1990, Submitted
- Arnett F C, Edworthy S M, Bloch D A, McShane D J, Fries J F, Cooper N S, et al. The American Rheumatism Association 1987 revised criteria for the classification of RA. Arthritis Rheum 1988; 31: 315–324
- Tan E M, Cohen A S, Fries J F, Masi A T, McShane D J, Rothfield N F, Schaller J G, Talal N, Winchester R J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
- Kao K J, Scornik J C, Riley W J, McQueen C F. Association between HLA phenotype and HLA concentration in plasma or platelets. Human Immunol 1988; 21: 115–124
- Stastny P. Association of the B-cell alloantigen DR3 with rheumatoid arthritis. N Engl J Med 1978; 298: 869–871
- Sveggard A, Platz P, Ryder L P. HLA and disease 1982 - A survey. Imm Rev 1983; 70: 193–218
- Steere A C, Feld J, Winchester R. Association of chronic Lyme arthritis with increased frequencies of DR4 and 3. Arthritis Rheum 1988; 31: 598, abstract
- Volkman D J, Mann D L, Fauci A S. Association between Takayasu's arteritis and a B-cell alloantigen in North Americans. N Engl J Med 1982; 306: 464–465
- Calamia K T, Moore S B, Elveback L R, Hunder G G. HLA-DR locus antigens in polymyalgia rheumatic and giant cell arteritis. J Rheumatol 1981; 8: 6–9
- Steeg P S, Moore R N, Johnson H M, Oppenheim J J. Regulation of murine la Antigen expression by a lymphokine with immune interferon activity. J Exp Med 1982; 156: 1780–1793
- Pujol-Borrell R, Todd I, Doshi M, Bottazzo G F, Sutton R, Gray D. HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin. Nature 1987; 326: 304–306
- Milton A D, Spencer S C, Fabre J W. The effects of cyclosporin on the induction of donor class 1 and class It MHC antigens in heart and kidney allografts in the rat. Transplantation 1986; 42: 337–347
- Snyder D S, Wright C L, Ting C. Inhibition of human monocyte antigen presentation, but not HLA-DR expression by cyclosporine. Transplantation 1987; 44: 407–412
- Granelli-Piperno A, Andrus L, Steinman R M. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. J Exp Med 1986; 163: 922–937
- Cannon G W, Pincus S H, Emkey R D, Denes A, Cohen S A, Wolfe F, et al. Double-blind trial of recombinant y-interferon versus placebo in the treatment of rheumatoid arthritis. Arth and Rheum 1989; 32: 964–973
- Sette A, Buus S, Appella E, Smith J A, Chesnut R, Miles C, et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci USA 1989; 86: 3296–3300